光束治療公司
MX ˙ BMV ˙ US07373V1052
SecurityMX:BEAM / Beam Therapeutics Inc.
InstitutionWalleye Trading LLC
Latest Disclosed Ownership183 shares
Latest Disclosed Value $ 4,361
Walleye Trading LLC ownership in BEAM / Beam Therapeutics Inc.

On May 8, 2026 - Walleye Trading LLC filed a 13F-HR form disclosing ownership of 183 shares of Beam Therapeutics Inc. (MX:BEAM) valued at $4,361 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 14, 2025 disclosing 0 shares of Beam Therapeutics Inc..

Walleye Trading LLC has a history of taking positions in derivatives of the underlying security (BEAM) in the form of stock options. The firm currently holds call options representing 8,500 of underlying shares valued at $202,555 USD and put options representing 1,800 of underlying shares valued at $42,894 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:BEAM / Beam Therapeutics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F BEAM THERAPEUTICS COM 07373V105 183 183 4 0.0000
2025-11-14 2025-09-30 13F BEAM THERAPEUTICS COM 07373V105 0 -3,478 -100.00 0 -100.00
2025-08-13 2025-06-30 13F BEAM THERAPEUTICS COM 07373V105 3,478 3,478 59 0.0001
2023-11-21 2023-09-30 13F/A-1 BEAM THERAPEUTICS COM 07373V105 0 -6,129 -100.00 0 -100.00
2023-11-14 2023-09-30 13F BEAM THERAPEUTICS COM 07373V105 0 -6,129 0
2023-08-14 2023-06-30 13F BEAM THERAPEUTICS COM 07373V105 6,129 5,293 633.13 196 680.00 0.0006
2023-05-15 2023-03-31 13F BEAM THERAPEUTICS COM 07373V105 836 -12,164 -93.57 26 -95.08 0.0001
2023-02-14 2022-12-31 13F BEAM THERAPEUTICS COM 07373V105 13,000 13,000 508 0.0015
2022-11-14 2022-09-30 13F BEAM THERAPEUTICS COM 07373V105 0 -1,094 -100.00 0 -100.00
2022-08-08 2022-06-30 13F BEAM THERAPEUTICS COM 07373V105 1,094 1,094 42 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F BEAM THERAPEUTICS COM Call 8,500 -54.05 203 -60.55 n/a n/a n/a
2026-02-13 2025-12-31 13F BEAM THERAPEUTICS COM Call 18,500 15.62 513 31.96 n/a n/a n/a
2025-11-14 2025-09-30 13F BEAM THERAPEUTICS COM Call 16,000 247.83 388 397.44 n/a n/a n/a
2025-08-13 2025-06-30 13F BEAM THERAPEUTICS COM Call 4,600 78 n/a n/a n/a
2024-05-15 2024-03-31 13F BEAM THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F BEAM THERAPEUTICS COM Call 30,700 130.83 836 161.76 n/a n/a n/a
2023-11-21 2023-09-30 13F/A BEAM THERAPEUTICS COM Call 13,300 -77.15 320 -82.83 n/a n/a n/a
2023-11-14 2023-09-30 13F BEAM THERAPEUTICS COM Call 13,300 320 n/a n/a n/a
2023-08-14 2023-06-30 13F BEAM THERAPEUTICS COM Call 58,200 103.50 1,858 112.34 n/a n/a n/a
2023-05-15 2023-03-31 13F BEAM THERAPEUTICS COM Call 28,600 19.17 876 -6.72 n/a n/a n/a
2023-02-14 2022-12-31 13F BEAM THERAPEUTICS COM Call 24,000 -63.80 939 -70.31 n/a n/a n/a
2022-11-14 2022-09-30 13F BEAM THERAPEUTICS COM Call 66,300 563.00 3,159 716.28 n/a n/a n/a
2022-08-08 2022-06-30 13F BEAM THERAPEUTICS COM Call 10,000 132.56 387 57.32 n/a n/a n/a
2022-05-16 2022-03-31 13F BEAM THERAPEUTICS COM Call 4,300 246 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-08 2026-03-31 13F BEAM THERAPEUTICS COM Put 1,800 -76.92 43 -80.56 n/a n/a n/a
2026-02-13 2025-12-31 13F BEAM THERAPEUTICS COM Put 7,800 -75.47 216 -71.98 n/a n/a n/a
2025-11-14 2025-09-30 13F BEAM THERAPEUTICS COM Put 31,800 292.59 772 462.77 n/a n/a n/a
2025-08-13 2025-06-30 13F BEAM THERAPEUTICS COM Put 8,100 138 n/a n/a n/a
2024-05-15 2024-03-31 13F BEAM THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F BEAM THERAPEUTICS COM Put 27,400 17.60 746 33.04 n/a n/a n/a
2023-11-21 2023-09-30 13F/A BEAM THERAPEUTICS COM Put 23,300 -8.98 560 -31.46 n/a n/a n/a
2023-11-14 2023-09-30 13F BEAM THERAPEUTICS COM Put 23,300 560 n/a n/a n/a
2023-08-14 2023-06-30 13F BEAM THERAPEUTICS COM Put 25,600 47.98 817 54.44 n/a n/a n/a
2023-05-15 2023-03-31 13F BEAM THERAPEUTICS COM Put 17,300 -47.73 530 -59.12 n/a n/a n/a
2023-02-14 2022-12-31 13F BEAM THERAPEUTICS COM Put 33,100 3.44 1,295 -15.09 n/a n/a n/a
2022-11-14 2022-09-30 13F BEAM THERAPEUTICS COM Put 32,000 263.64 1,524 346.92 n/a n/a n/a
2022-08-08 2022-06-30 13F BEAM THERAPEUTICS COM Put 8,800 125.64 341 52.91 n/a n/a n/a
2022-05-16 2022-03-31 13F BEAM THERAPEUTICS COM Put 3,900 223 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.